Cygnus Bio is a biotechnology company specializing in advanced DNA sequencing technologies. The company serves a diverse range of clients, including research institutions, healthcare providers, and pharmaceutical companies. Operating in the rapidly growing genomics market, Cygnus Bio's core product, the Cygnus S100 DNA sequencer, is designed to deliver accurate, fast, flexible, and economical sequencing solutions. The business model is centered around the sale of its proprietary sequencing hardware and consumables, as well as offering sequencing services. Revenue is generated through direct sales, service contracts, and partnerships with key industry players. Cygnus Bio aims to revolutionize the genomics field by making high-quality DNA sequencing accessible and affordable for a broad spectrum of applications.

Keywords: DNA sequencing, biotechnology, genomics, healthcare, research, pharmaceutical, accuracy, speed, flexibility, cost-effective.